Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company whose news flow centers on deployments, partnerships, regulatory developments, and capital markets activity related to its SteraMist systems and Binary Ionization Technology (BIT) platform. The company’s announcements highlight how its ionized Hydrogen Peroxide (iHP) technology is integrated into high-stakes environments where contamination control and infection prevention are essential.
Recent news releases describe multi-stage SteraMist iHP implementations at cell and gene therapy manufacturing sites, integration of SteraMist Integrated Systems into critical pharmaceutical manufacturing infrastructure, and installation of a SteraMist Hybrid System in a research university facility for reusable medical product sterilization. TOMI also reports on its role in life sciences and medical device sectors through a custom integration pipeline involving SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms, supported by partnerships with enclosure manufacturers.
Investors and industry observers following TOMZ news will find updates on TOMI’s outreach to cruise lines for advanced maritime decontamination, participation in sector events such as the American Association for Laboratory Animal Science National Meeting, and expansion into animal research and academic markets. The company’s releases also cover financial milestones, including quarterly results, pipeline updates, universal shelf registration filings, equity line of credit arrangements, and Nasdaq listing compliance notices.
This news page aggregates these disclosures, offering a centralized view of TOMI’s commercial projects, strategic relationships, regulatory and financing steps, and sector-focused initiatives involving its SteraMist and BIT-based disinfection technology.
TOMI Environmental Solutions (NASDAQ: TOMZ) reported its Q4 and full-year 2024 financial results, showing mixed performance. Annual revenue increased by 5% to $7.74 million, with international revenue growing 33%. However, the company faced significant challenges with GAAP net loss widening to $(4.48 million) or $(0.22) per share in 2024, compared to $(3.40 million) or $(0.17) per share in 2023.
Q4 2024 showed particular weakness with net sales declining to $1.07 million from $1.53 million in Q4 2023, and gross margin turning negative at -49.5%. However, preliminary Q1 2025 results indicate a strong rebound with revenue up 42% to $1.58 million and solution sales growing approximately 200% quarter-over-quarter. The company's sales backlog increased 40% to $1.23 million by March 2025.
TOMI Environmental Solutions (NASDAQ: TOMZ) has scheduled its Q4 2024 earnings conference call for April 14, 2025, at 4:30 p.m. ET, following the release of financial results after market close. The company specializes in disinfection and decontamination solutions through its proprietary Binary Ionization Technology (BIT) platform.
Investors can access the call by dialing (888) 506-0062 (US) or (973) 528-0011 (International) with access code 818389. A webcast replay will be available for 90 days, and telephone replay until April 28, 2025, using code 52313.
TOMI's BIT platform, developed under a DARPA defense grant, uses ionized Hydrogen Peroxide (iHP) technology for superior disinfection across various sectors including healthcare, biosafety, pharmaceutical, commercial, and public safety facilities.
TOMI Environmental Solutions (NASDAQ: TOMZ) has announced an OEM partnership with Pharma Biotech System Components (PBSC) to enhance its SteraMist Integrated System (SIS) product line. Through this collaboration, TOMI will offer pass-through hatches and chambers integrated with iHP technology for optimized decontamination cycles.
PBSC, a leading manufacturer of cleanroom and high containment solutions, serves pharmaceutical, medical research, and hospital sectors worldwide. The partnership leverages PBSC's expertise in high-containment enclosures while expanding SteraMist adoption in critical industries. Several projects are currently in progress, demonstrating strong market demand for this innovative system.
The partnership enhances TOMI's Binary Ionization Technology® (BIT™) platform, which uses low percentage hydrogen peroxide and patented ionized Hydrogen Peroxide (iHP™) technology for superior disinfection across various sectors including hospitals, biosafety labs, and pharmaceutical facilities.
TOMI Environmental Solutions (NASDAQ: TOMZ) has secured a significant $450,000 contract to install a SteraMist iHP Custom Engineered System (CES) at a leading Rhode Island university. The contract, secured through distributor ARES Distribution, demonstrates TOMI's competitive edge over hydrogen peroxide competitors.
The company is also in negotiations with a long-standing Boston client for a CES upgrade and expansion project. Earlier this quarter, TOMI added a SteraPak system sale at a Massachusetts private university. The company's New England territory portfolio now includes over 20 biotechnology, pharmaceutical, and research university customers.
TOMI's Binary Ionization Technology® (BIT™) platform, originally developed under a DARPA defense grant, uses ionized Hydrogen Peroxide (iHP™) technology for superior disinfection and decontamination solutions.
TOMI Environmental Solutions (NASDAQ: TOMZ) has successfully implemented its SteraMist technology at Algafeed, a company specializing in large-scale microalgae production for aquaculture. The partnership addresses Algafeed's challenge with Protozoan ciliate contamination in algae cultivation.
The implementation has effectively reduced ciliate contamination to levels that no longer impact target production volumes. Algafeed's innovative technology enables the cultivation and delivery of high-density microalgae, serving as a primary food source for shrimp, shellfish, and finfish farms.
SteraMist technology, developed under a DARPA defense grant, uses Binary Ionization Technology® (BIT™) platform with low percentage hydrogen peroxide as its active ingredient. The successful implementation demonstrates TOMI's ability to expand into the aquaculture sector while providing effective contamination solutions.
TOMI Environmental Solutions (NASDAQ: TOMZ) has announced the deployment of its SteraMist iHP technology at the NASA Johnson Space Center, marking its entry into the aerospace sector. The technology, developed through DARPA, will be used in a biosafety cabinet for handling Mars Perseverance Rover mission samples.
The deployment, facilitated through TOMI's distributor ARES Distribution, is in the final qualification process and has shown promising results in meeting NASA's planetary protection requirements. This initiative is part of TOMI's SteraMistX campaign, which focuses on aerospace, military, and exploration fields.
The company's Binary Ionization Technology® (BIT™) platform uses a low percentage hydrogen peroxide as its active ingredient and employs patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems for superior disinfection.
TOMI Environmental Solutions (NASDAQ: TOMZ), a global disinfection and decontamination company, has announced its participation in the upcoming Q1 Investor Summit Event. Dr. Halden Shane, Chairman and CEO, will present virtually on March 11, 2025, at 10:30 am Eastern Time.
The company specializes in Binary Ionization Technology (BIT) platform through its SteraMist products. The technology, developed under a defense grant with DARPA, uses ionized Hydrogen Peroxide (iHP) technology with a low percentage hydrogen peroxide as its active ingredient.
TOMI's disinfection solutions serve diverse sectors including:
- Hospitals and medical facilities
- Biosafety labs
- Pharmaceutical facilities
- Commercial buildings
- Schools
- Restaurants
- Meat and produce processing facilities
- Police and fire departments